110 related articles for article (PubMed ID: 30098826)
1. Utility of temporal profiles of new cardio-renal and pulmonary candidate biomarkers in chronic heart failure.
Brankovic M; Martijn Akkerhuis K; Mouthaan H; Constantinescu A; Caliskan K; van Ramshorst J; Germans T; Umans V; Kardys I
Int J Cardiol; 2019 Feb; 276():157-165. PubMed ID: 30098826
[TBL] [Abstract][Full Text] [Related]
2. Cardiometabolic Biomarkers and Their Temporal Patterns Predict Poor Outcome in Chronic Heart Failure (Bio-SHiFT Study).
Brankovic M; Akkerhuis KM; Mouthaan H; Brugts JJ; Manintveld OC; van Ramshorst J; Germans T; Umans V; Boersma E; Kardys I
J Clin Endocrinol Metab; 2018 Nov; 103(11):3954-3964. PubMed ID: 30113647
[TBL] [Abstract][Full Text] [Related]
3. Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the Bio-SHiFT study.
Brankovic M; Akkerhuis KM; van Boven N; Anroedh S; Constantinescu A; Caliskan K; Manintveld O; Cornel JH; Baart S; Rizopoulos D; Hillege H; Boersma E; Umans V; Kardys I
Kidney Int; 2018 Apr; 93(4):952-960. PubMed ID: 29191357
[TBL] [Abstract][Full Text] [Related]
4. Temporal Patterns of 14 Blood Biomarker candidates of Cardiac Remodeling in Relation to Prognosis of Patients With Chronic Heart Failure-The Bio- SH i FT Study.
Bouwens E; Brankovic M; Mouthaan H; Baart S; Rizopoulos D; van Boven N; Caliskan K; Manintveld O; Germans T; van Ramshorst J; Umans V; Akkerhuis KM; Kardys I
J Am Heart Assoc; 2019 Feb; 8(4):e009555. PubMed ID: 30760105
[TBL] [Abstract][Full Text] [Related]
5. Renal tubular damage and worsening renal function in chronic heart failure: Clinical determinants and relation to prognosis (Bio-SHiFT study).
Brankovic M; Akkerhuis KM; Hoorn EJ; van Boven N; van den Berge JC; Constantinescu A; Brugts J; van Ramshorst J; Germans T; Hillege H; Boersma E; Umans V; Kardys I
Clin Cardiol; 2020 Jun; 43(6):630-638. PubMed ID: 32298007
[TBL] [Abstract][Full Text] [Related]
6. HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart Failure.
Piek A; Meijers WC; Schroten NF; Gansevoort RT; de Boer RA; Silljé HH
J Card Fail; 2017 Jan; 23(1):12-19. PubMed ID: 27224553
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Serial ST2 Measurements in Patients With Acute Heart Failure.
van Vark LC; Lesman-Leegte I; Baart SJ; Postmus D; Pinto YM; Orsel JG; Westenbrink BD; Brunner-la Rocca HP; van Miltenburg AJM; Boersma E; Hillege HL; Akkerhuis KM;
J Am Coll Cardiol; 2017 Nov; 70(19):2378-2388. PubMed ID: 29096809
[TBL] [Abstract][Full Text] [Related]
8. N-Terminal Pro-B-Type Natriuretic Peptide-Guided Therapy in Chronic Heart Failure Reduces Repeated Hospitalizations-Results From TIME-CHF.
Davarzani N; Sanders-van Wijk S; Karel J; Maeder MT; Leibundgut G; Gutmann M; Pfisterer ME; Rickenbacher P; Peeters R; Brunner-la Rocca HP
J Card Fail; 2017 May; 23(5):382-389. PubMed ID: 28232046
[TBL] [Abstract][Full Text] [Related]
9. Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure.
Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Verdiani V; Tijssen JG; Pinto YM
JACC Heart Fail; 2015 Oct; 3(10):751-61. PubMed ID: 26449995
[TBL] [Abstract][Full Text] [Related]
10. Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure.
Miller WL; Hartman KA; Grill DE; Burnett JC; Jaffe AS
Clin Chem; 2009 Jan; 55(1):78-84. PubMed ID: 19028821
[TBL] [Abstract][Full Text] [Related]
11. The predictive capacity and additional prognostic power of N-terminal pro-B-type natriuretic peptide in Chinese elderly with chronic heart failure.
Fu S; Xie L; Li D; Ye P; Luo L
Clin Interv Aging; 2015; 10():359-65. PubMed ID: 25670892
[TBL] [Abstract][Full Text] [Related]
12. Predictive biomarkers for death and rehospitalization in comorbid frail elderly heart failure patients.
Pacho C; Domingo M; Núñez R; Lupón J; Núñez J; Barallat J; Moliner P; de Antonio M; Santesmases J; Cediel G; Roura S; Pastor MC; Tor J; Bayes-Genis A
BMC Geriatr; 2018 May; 18(1):109. PubMed ID: 29743019
[TBL] [Abstract][Full Text] [Related]
13. Correlations between serum intact parathyroid hormone (PTH) and N-terminal-probrain natriuretic peptide levels in elderly patients with chronic heart failure (CHF).
Zhang S; Hu Y; Zhou L; Chen X; Wang Y; Wu J; He H; Gao Y
Arch Gerontol Geriatr; 2015; 60(2):359-65. PubMed ID: 25466512
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of various biomarkers in adults with pulmonary hypertension; a multi-biomarker approach.
Geenen LW; Baggen VJM; Koudstaal T; Boomars KA; Eindhoven JA; Boersma E; Roos-Hesselink JW; van den Bosch AE
Am Heart J; 2019 Feb; 208():91-99. PubMed ID: 30580131
[TBL] [Abstract][Full Text] [Related]
15. Temporal evolution of liver function parameters predicts clinical outcome in chronic heart failure patients (Bio-SHiFT study).
Klimczak-Tomaniak D; Andrzejczyk K; Abou Kamar S; Baart S; van Boven N; Akkerhuis KM; Constantinescu A; Caliskan K; Simsek S; Germanse T; van Ramshorst J; Brugts J; Kuch M; Umans V; Boersma E; Kardys I
Cardiol J; 2024; 31(3):409-417. PubMed ID: 38408202
[TBL] [Abstract][Full Text] [Related]
16. Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study.
Park M; Vittinghoff E; Shlipak MG; Mishra R; Whooley M; Bansal N
Am Heart J; 2014 Dec; 168(6):931-9.e2. PubMed ID: 25458658
[TBL] [Abstract][Full Text] [Related]
17. Natriuretic and Inflammatory Biomarkers as Risk Predictors of Heart Failure in Middle-Aged Men From the General Population: A 21-Year Follow-Up.
Ergatoudes C; Thunström E; Hansson PO; Morales D; Mandalenakis Z; Rosengren A; Zhong Y; Caidahl K; Fu M
J Card Fail; 2018 Sep; 24(9):594-600. PubMed ID: 30048772
[TBL] [Abstract][Full Text] [Related]
18. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.
Rothenburger M; Wichter T; Schmid C; Stypmann J; Tjan TD; Berendes E; Etz C; Pioux A; Löher A; Wenzelburger F; Drees G; Hoffmeier A; Breithardt G; Scheld HH
J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114
[TBL] [Abstract][Full Text] [Related]
19. Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study.
van Boven N; Akkerhuis KM; Anroedh SS; Rizopoulos D; Pinto Y; Battes LC; Hillege HL; Caliskan KC; Germans T; Manintveld OC; Cornel JH; Constantinescu AA; Boersma E; Umans VA; Kardys I
Int J Cardiol; 2017 May; 235():124-132. PubMed ID: 28274577
[TBL] [Abstract][Full Text] [Related]
20. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
